OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipidomics reveals immune-related adverse events in NSCLC patients receiving immune checkpoint inhibitor
Jia Yu, Fen Xiong, Yingruo Xu, et al.
International Immunopharmacology (2023) Vol. 127, pp. 111412-111412
Closed Access | Times Cited: 8

Showing 8 citing articles:

Therapeutic effects of tetrandrine in inflammatory diseases: a comprehensive review
Jiawen Song, Yushi Liu, Yurou Guo, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 3, pp. 1743-1757
Closed Access | Times Cited: 8

Integration of clinical phenoms and metabolomics facilitates precision medicine for lung cancer
Furong Yan, Chanjuan Liu, Dongli Song, et al.
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 2

The impact of BDNF and CD4 + T cell crosstalk on depression
Michel‐Edwar Mickael, Norwin Kubick, Małgorzata Dragan, et al.
Immunologic Research (2024) Vol. 72, Iss. 5, pp. 883-894
Closed Access | Times Cited: 1

Plasma metabolomics of immune-related adverse events for patients with lung cancer treated with PD-1/PD-L1 inhibitors
Juan Chen, Jia-Si Liu, Junyan Liu, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 7, pp. e009399-e009399
Open Access | Times Cited: 1

Levels of serum lipids predict responses to PD-L1 inhibitor as first-line treatment in small cell lung cancer: an observational study
Qiaoli Chen, Wei Zhang, Ping Shu, et al.
Research Square (Research Square) (2024)
Closed Access

Lipidomics reveals biomarkers of the efficacy of first-line ICIs therapy combined with chemotherapy in NSCLC
Jia Yu, Hanyan Xu, Fen Xiong, et al.
Research Square (Research Square) (2024)
Closed Access

Page 1

Scroll to top